Acro Biomedical Co Operating Income Growth & History (ACBM)

Acro Biomedical Co's operating income was −$154,024 for fiscal 2025.

View full Acro Biomedical Co company overview

Acro Biomedical Co annual operating income history

Acro Biomedical Co annual operating income

Fiscal yearPeriod endedOperating incomeChangeGrowth
20252025-12-31−$154,024−$116,066
20242024-12-31−$37,958$8.8M
20232023-12-31−$8.8M$7.1M
20222022-12-31−$15.9M−$8.2M
20212021-12-31−$7.7M−$7.6M
20202020-12-31−$130,463$292,288
2019 · Dec 312019-12-31−$422,751
2019 · Sep 302019-09-30−$441,553−$957,103
20182018-09-30$515,550$517,798
20172017-09-30−$2,248−$45,676
20162016-09-30$43,428

Acro Biomedical Co operating income trends

Over the last five fiscal years, Acro Biomedical Co's operating income decreased from −$130,463 to −$154,024, a change of −$23,561. The latest reported quarter, Q2 2026, shows −$17,554.

About the metric

What operating income means

Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.

Calculation and source

SEC-reported operating income

TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Acro Biomedical Co source filings ↗

Community posts

It’s quiet here.

No posts about ACBM yet. Start the conversation.

Write the first post